We explore a large-scale real-world analysis based on UK Office for National Statistics (ONS) data (April 2021–May 2023), examining all-cause mortality by vaccination status.
The data show that the initial rollout of COVID-19 vaccines provided substantial mortality protection, especially among older populations. However, this protective effect declined over time, revealing a more nuanced picture by age group and booster status.
🔍 What you'll learn:
• Initial vaccine protection and when it peaked
• Age-stratified risk trends over time
• Booster dose impact on longevity of protection
• Patterns in non-COVID deaths
• Duration of benefit by age and dose count
This video unpacks both the benefits and complexities of long-term mortality trends post-vaccination—based solely on publicly available data.
📊 Timestamps:
00:00 – Introduction & Title
00:20 – Excess deaths Videos
04:00 – 18-39 age group mortality rate ratio by vaccine status
05:35 – 40-49 age group mortality rate ratio by vaccine status
07:30 – 50-59 age group mortality rate ratio by vaccine status
11:05 – 60-69 age group mortality rate ratio by vaccine status
14:10 – 70-79 age group mortality rate ratio by vaccine status
16:16 – 80-89 age group mortality rate ratio by vaccine status
18:55 – 90+ age group mortality rate ratio by vaccine status
22:25 – 18-39 age group standardized mortality ratio of all vaxx vs non-vaxx24:00 – 40-49 age group standardized mortality ratio of all vaxx vs non-vaxx
25:17 – 50-59 age group standardized mortality ratio of all vaxx vs non-vaxx
26:10 – 60-69 age group standardized mortality ratio of all vaxx vs non-vaxx
26:37 – 70-79 age group standardized mortality ratio of all vaxx vs non-vaxx
27:00 – 80-89 age group standardized mortality ratio of all vaxx vs non-vaxx
27:55 – 90+ age group standardized mortality ratio of all vaxx vs non-vaxx
29:55 – Non-specific vaccine effects
🧪 Study source:
https://f1000research.com/articles/13...
🎥 Filming Location: Bow Summit, Alberta